Application of the synthetic α-MSH analog, Afamelanotide ([Nle4-D-Phe7]-α-MSH), alleviates dermatological disorders, including polymorphic light eruption, erythropoietic protoporphyria, and vitiligo [9,10]. This evidence concerns the gene STAMBP and vitiligo.